In an effort to more reliably target AML cells, researchers have recently sought to identify patterns that are specifically activated in AML cells including the apoptosis, receptor tyrosine kinase (RTK) signaling, hedgehog (HH), mitochondrial function, DNA repair, and c-Myc signaling pathways (2). The gene discussed is NTRK1; the disease is acute myeloid leukemia.